US Stock MarketDetailed Quotes

ABT Abbott Laboratories

Watchlist
  • 106.860
  • -0.030-0.03%
Close Apr 25 16:00 ET
  • 106.810
  • -0.050-0.05%
Post 19:53 ET
185.42BMarket Cap33.29P/E (TTM)

Abbott Laboratories Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
2.23%9.96B
-8.12%40.11B
1.49%10.24B
-2.56%10.14B
-11.36%9.98B
-18.06%9.75B
1.34%43.65B
-12.01%10.09B
-4.74%10.41B
10.11%11.26B
Operating revenue
2.23%9.96B
-8.12%40.11B
1.49%10.24B
-2.56%10.14B
-11.36%9.98B
-18.06%9.75B
1.34%43.65B
-12.01%10.09B
-4.74%10.41B
10.11%11.26B
Cost of revenue
3.05%4.46B
-6.10%17.98B
-0.81%4.56B
-0.52%4.61B
-9.12%4.48B
-13.15%4.33B
3.26%19.14B
-3.63%4.59B
4.66%4.63B
-0.28%4.93B
Gross profit
1.57%5.5B
-9.70%22.13B
3.40%5.69B
-4.20%5.54B
-13.11%5.5B
-21.60%5.42B
-0.11%24.51B
-17.96%5.5B
-11.13%5.78B
19.86%6.32B
Operating expense
5.32%4.12B
-3.05%15.66B
-6.89%3.91B
-2.99%3.89B
0.13%3.95B
-2.23%3.91B
0.22%16.15B
-3.01%4.19B
1.31%4.01B
1.65%3.95B
Selling and administrative expenses
7.13%2.96B
-2.66%10.95B
-8.38%2.72B
-0.29%2.72B
-0.62%2.74B
-0.90%2.76B
-0.67%11.25B
-2.46%2.97B
-1.30%2.73B
1.14%2.76B
Research and development costs
4.59%684M
-5.09%2.74B
-3.45%700M
-14.07%672M
4.53%715M
-6.17%654M
5.32%2.89B
-4.86%725M
16.37%782M
4.59%684M
Depreciation amortization depletion
-3.87%472M
-2.33%1.97B
-3.02%481M
-0.40%496M
-1.78%498M
-4.10%491M
-1.66%2.01B
-3.50%496M
-4.23%498M
0.60%507M
-Depreciation and amortization
-3.87%472M
-2.33%1.97B
-3.02%481M
-0.40%496M
-1.78%498M
-4.10%491M
-1.66%2.01B
-3.50%496M
-4.23%498M
0.60%507M
Operating profit
-8.15%1.39B
-22.53%6.48B
36.50%1.78B
-6.95%1.65B
-35.10%1.54B
-48.18%1.51B
-0.75%8.36B
-45.16%1.3B
-30.48%1.77B
70.69%2.38B
Net non-operating interest income expense
-17.31%-61M
32.80%-252M
-6.06%-70M
19.77%-69M
42.45%-61M
55.56%-52M
23.47%-375M
45.00%-66M
30.08%-86M
13.82%-106M
Non-operating interest income
----
110.38%385M
1.14%89M
76.36%97M
276.92%98M
621.43%101M
325.58%183M
700.00%88M
450.00%55M
136.36%26M
Non-operating interest expense
-60.13%61M
14.16%637M
3.25%159M
17.73%166M
20.45%159M
16.79%153M
4.69%558M
17.56%154M
6.02%141M
-1.49%132M
Other net income (expense)
5.71%111M
37.30%438M
3.66%85M
25.68%93M
89.02%155M
29.63%105M
15.58%319M
18.84%82M
5.71%74M
3.80%82M
Gain on sale of security
----
-1,950.00%-41M
-271.43%-24M
152.63%10M
---21M
-300.00%-6M
-100.00%-2M
133.33%14M
-375.00%-19M
----
Other non- operating income (expenses)
0.00%111M
49.22%479M
60.29%109M
-10.75%83M
114.63%176M
42.31%111M
15.88%321M
7.94%68M
25.68%93M
3.80%82M
Income before tax
-8.07%1.44B
-19.77%6.66B
35.98%1.8B
-4.95%1.67B
-30.44%1.64B
-45.69%1.56B
1.16%8.31B
-43.27%1.32B
-29.48%1.76B
74.48%2.35B
Income tax
-13.52%211M
-31.46%941M
-29.97%201M
-27.24%235M
-21.86%261M
-43.12%244M
20.44%1.37B
-15.09%287M
-17.81%323M
110.06%334M
Net income
-7.06%1.23B
-17.45%5.72B
54.31%1.59B
0.07%1.44B
-31.86%1.38B
-46.14%1.32B
-1.95%6.93B
-48.06%1.03B
-31.67%1.44B
69.72%2.02B
Net income continuous Operations
-7.06%1.23B
-17.45%5.72B
54.31%1.59B
0.07%1.44B
-31.86%1.38B
-46.14%1.32B
-1.95%6.93B
-48.06%1.03B
-31.67%1.44B
69.72%2.02B
Minority interest income
Net income attributable to the parent company
-7.06%1.23B
-17.45%5.72B
54.31%1.59B
0.07%1.44B
-31.86%1.38B
-46.14%1.32B
-1.95%6.93B
-48.06%1.03B
-31.67%1.44B
69.72%2.02B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-7.06%1.23B
-17.45%5.72B
54.31%1.59B
0.07%1.44B
-31.86%1.38B
-46.14%1.32B
-1.95%6.93B
-48.06%1.03B
-31.67%1.44B
69.72%2.02B
Basic earnings per share
-5.87%0.706
-16.75%3.28
54.64%0.9192
0.00%0.82
-31.30%0.79
-45.65%0.75
-0.76%3.94
-47.28%0.5944
-30.51%0.82
71.64%1.15
Diluted earnings per share
-6.67%0.7
-16.62%3.26
54.24%0.91
1.23%0.82
-31.58%0.78
-45.26%0.75
-0.76%3.91
-46.85%0.59
-30.77%0.81
72.73%1.14
Dividend per share
7.84%0.55
8.51%2.04
8.51%0.51
8.51%0.51
8.51%0.51
8.51%0.51
4.44%1.88
4.44%0.47
4.44%0.47
4.44%0.47
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 2.23%9.96B-8.12%40.11B1.49%10.24B-2.56%10.14B-11.36%9.98B-18.06%9.75B1.34%43.65B-12.01%10.09B-4.74%10.41B10.11%11.26B
Operating revenue 2.23%9.96B-8.12%40.11B1.49%10.24B-2.56%10.14B-11.36%9.98B-18.06%9.75B1.34%43.65B-12.01%10.09B-4.74%10.41B10.11%11.26B
Cost of revenue 3.05%4.46B-6.10%17.98B-0.81%4.56B-0.52%4.61B-9.12%4.48B-13.15%4.33B3.26%19.14B-3.63%4.59B4.66%4.63B-0.28%4.93B
Gross profit 1.57%5.5B-9.70%22.13B3.40%5.69B-4.20%5.54B-13.11%5.5B-21.60%5.42B-0.11%24.51B-17.96%5.5B-11.13%5.78B19.86%6.32B
Operating expense 5.32%4.12B-3.05%15.66B-6.89%3.91B-2.99%3.89B0.13%3.95B-2.23%3.91B0.22%16.15B-3.01%4.19B1.31%4.01B1.65%3.95B
Selling and administrative expenses 7.13%2.96B-2.66%10.95B-8.38%2.72B-0.29%2.72B-0.62%2.74B-0.90%2.76B-0.67%11.25B-2.46%2.97B-1.30%2.73B1.14%2.76B
Research and development costs 4.59%684M-5.09%2.74B-3.45%700M-14.07%672M4.53%715M-6.17%654M5.32%2.89B-4.86%725M16.37%782M4.59%684M
Depreciation amortization depletion -3.87%472M-2.33%1.97B-3.02%481M-0.40%496M-1.78%498M-4.10%491M-1.66%2.01B-3.50%496M-4.23%498M0.60%507M
-Depreciation and amortization -3.87%472M-2.33%1.97B-3.02%481M-0.40%496M-1.78%498M-4.10%491M-1.66%2.01B-3.50%496M-4.23%498M0.60%507M
Operating profit -8.15%1.39B-22.53%6.48B36.50%1.78B-6.95%1.65B-35.10%1.54B-48.18%1.51B-0.75%8.36B-45.16%1.3B-30.48%1.77B70.69%2.38B
Net non-operating interest income expense -17.31%-61M32.80%-252M-6.06%-70M19.77%-69M42.45%-61M55.56%-52M23.47%-375M45.00%-66M30.08%-86M13.82%-106M
Non-operating interest income ----110.38%385M1.14%89M76.36%97M276.92%98M621.43%101M325.58%183M700.00%88M450.00%55M136.36%26M
Non-operating interest expense -60.13%61M14.16%637M3.25%159M17.73%166M20.45%159M16.79%153M4.69%558M17.56%154M6.02%141M-1.49%132M
Other net income (expense) 5.71%111M37.30%438M3.66%85M25.68%93M89.02%155M29.63%105M15.58%319M18.84%82M5.71%74M3.80%82M
Gain on sale of security -----1,950.00%-41M-271.43%-24M152.63%10M---21M-300.00%-6M-100.00%-2M133.33%14M-375.00%-19M----
Other non- operating income (expenses) 0.00%111M49.22%479M60.29%109M-10.75%83M114.63%176M42.31%111M15.88%321M7.94%68M25.68%93M3.80%82M
Income before tax -8.07%1.44B-19.77%6.66B35.98%1.8B-4.95%1.67B-30.44%1.64B-45.69%1.56B1.16%8.31B-43.27%1.32B-29.48%1.76B74.48%2.35B
Income tax -13.52%211M-31.46%941M-29.97%201M-27.24%235M-21.86%261M-43.12%244M20.44%1.37B-15.09%287M-17.81%323M110.06%334M
Net income -7.06%1.23B-17.45%5.72B54.31%1.59B0.07%1.44B-31.86%1.38B-46.14%1.32B-1.95%6.93B-48.06%1.03B-31.67%1.44B69.72%2.02B
Net income continuous Operations -7.06%1.23B-17.45%5.72B54.31%1.59B0.07%1.44B-31.86%1.38B-46.14%1.32B-1.95%6.93B-48.06%1.03B-31.67%1.44B69.72%2.02B
Minority interest income
Net income attributable to the parent company -7.06%1.23B-17.45%5.72B54.31%1.59B0.07%1.44B-31.86%1.38B-46.14%1.32B-1.95%6.93B-48.06%1.03B-31.67%1.44B69.72%2.02B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -7.06%1.23B-17.45%5.72B54.31%1.59B0.07%1.44B-31.86%1.38B-46.14%1.32B-1.95%6.93B-48.06%1.03B-31.67%1.44B69.72%2.02B
Basic earnings per share -5.87%0.706-16.75%3.2854.64%0.91920.00%0.82-31.30%0.79-45.65%0.75-0.76%3.94-47.28%0.5944-30.51%0.8271.64%1.15
Diluted earnings per share -6.67%0.7-16.62%3.2654.24%0.911.23%0.82-31.58%0.78-45.26%0.75-0.76%3.91-46.85%0.59-30.77%0.8172.73%1.14
Dividend per share 7.84%0.558.51%2.048.51%0.518.51%0.518.51%0.518.51%0.514.44%1.884.44%0.474.44%0.474.44%0.47
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg